Metastatic infection during Staphylococcus aureus bacteremia

Area of Science:

• Infectious Diseases
• Bacteriology
• Clinical Medicine

Background:

• Staphylococcus aureus causes diverse infections, potentially leading to bacteremia and subsequent metastatic infections.
• Metastatic infections complicate S. aureus bacteremia, impacting antimicrobial treatment duration and patient prognosis.
• Optimal treatment varies significantly, with uncomplicated cases requiring two weeks versus six weeks for endocarditis or vertebral osteomyelitis.

Purpose of the Study:

• To review the incidence, predictive factors, diagnosis, and treatment of metastatic infections in patients with S. aureus bacteremia.
• To clarify diagnostic approaches for metastatic infections beyond echocardiography.
• To identify key factors influencing patient outcomes and treatment strategies.

Main Methods:

• Literature review assessing clinical and experimental studies on S. aureus metastatic infections.
• Analysis of reported incidence and identified predictive factors.
• Evaluation of diagnostic modalities and treatment recommendations.

Main Results:

• Permanent foreign bodies and persistent bacteremia are identified as predictive factors for metastatic infections.
• While some virulence factors are linked to endocarditis, their role in metastatic risk is not fully established.
• Current diagnostic guidelines recommend echocardiography for endocarditis, but criteria for additional imaging (CT, MRI) remain unclear.

Conclusions:

• Metastatic infections represent a critical challenge in S. aureus bacteremia management.
• Accurate diagnosis and tailored treatment are essential to improve prognosis and prevent relapse.
• Further research is needed to refine diagnostic strategies and elucidate the role of virulence factors in metastatic spread.